Best TWAS P=7.18e-11 · Best GWAS P=1.16e-10 conditioned to 0.253
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adrenal Gland | RASIP1 | 0.20 | 0.11 | lasso | 4 | 0.10 | 2.4e-04 | 5.3 | -5.3 | 1.4e-07 | 0.84 | 0.03 | 0.93 | FALSE |
2 | GTEx | Cells Transformed fibroblasts | RASIP1 | 0.19 | 0.14 | lasso | 6 | 0.20 | 6.1e-15 | -6.0 | -6.5 | 7.2e-11 | 0.92 | 0.02 | 0.98 | TRUE |
3 | GTEx | Esophagus Mucosa | RASIP1 | 0.13 | 0.13 | lasso | 4 | 0.13 | 9.0e-09 | 5.7 | -5.7 | 1.2e-08 | 0.92 | 0.04 | 0.96 | FALSE |
4 | GTEx | Heart Left Ventricle | MAMSTR | 0.26 | 0.18 | lasso | 6 | 0.21 | 3.4e-11 | 4.2 | -5.4 | 5.8e-08 | 0.92 | 0.02 | 0.98 | FALSE |
5 | GTEx | Skin Not Sun Exposed Suprapubic | RASIP1 | 0.15 | 0.04 | lasso | 6 | 0.08 | 2.9e-05 | -6.4 | -5.5 | 4.1e-08 | 0.87 | 0.01 | 0.99 | FALSE |
6 | GTEx | Skin Not Sun Exposed Suprapubic | NTN5 | 0.19 | 0.07 | lasso | 5 | 0.08 | 2.5e-05 | -5.7 | -6.3 | 3.6e-10 | 0.89 | 0.04 | 0.95 | FALSE |
7 | GTEx | Skin Sun Exposed Lower leg | RASIP1 | 0.21 | 0.13 | enet | 19 | 0.17 | 1.1e-13 | 5.5 | -6.1 | 1.1e-09 | 0.92 | 0.01 | 0.99 | FALSE |
8 | GTEx | Skin Sun Exposed Lower leg | NTN5 | 0.11 | 0.09 | enet | 18 | 0.05 | 6.2e-05 | -6.0 | -5.8 | 7.3e-09 | 0.82 | 0.02 | 0.98 | FALSE |
9 | GTEx | Testis | RASIP1 | 0.29 | 0.20 | lasso | 8 | 0.30 | 7.5e-14 | 5.7 | -6.3 | 3.3e-10 | 0.96 | 0.03 | 0.97 | FALSE |
10 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FUT2 | 0.05 | 0.01 | blup | 52 | 0.01 | 6.1e-02 | -6.3 | 6.4 | 2.0e-10 | -0.94 | 0.01 | 0.84 | FALSE |
11 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FUT2 | 0.03 | 0.05 | blup | 54 | 0.05 | 1.9e-10 | -6.0 | 6.0 | 2.2e-09 | -0.84 | 0.05 | 0.95 | FALSE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | NTN5 | 0.02 | 0.01 | enet | 11 | 0.01 | 7.6e-04 | -5.6 | -6.0 | 1.4e-09 | 0.68 | 0.01 | 0.91 | FALSE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | RASIP1 | 0.02 | 0.02 | blup | 56 | 0.03 | 3.8e-07 | -5.6 | -6.3 | 3.4e-10 | 0.92 | 0.02 | 0.98 | FALSE |
14 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | FUT2 | 0.10 | 0.02 | blup | 55 | 0.06 | 6.8e-04 | -5.6 | 6.0 | 2.1e-09 | -0.83 | 0.07 | 0.89 | FALSE |
15 | The Cancer Genome Atlas | Colon Adenocarcinoma | FUT2 | 0.18 | 0.22 | enet | 12 | 0.18 | 6.8e-11 | -5.7 | 5.8 | 5.5e-09 | -0.81 | 0.13 | 0.87 | FALSE |
16 | The Cancer Genome Atlas | Colon Adenocarcinoma | SEC1 | 0.05 | 0.04 | enet | 11 | 0.01 | 8.5e-02 | -5.7 | 5.4 | 6.5e-08 | -0.73 | 0.02 | 0.85 | FALSE |
17 | The Cancer Genome Atlas | Esophageal Carcinoma | FUT2 | 0.33 | 0.27 | lasso | 3 | 0.24 | 3.9e-08 | 5.1 | 5.2 | 1.6e-07 | -0.67 | 0.15 | 0.84 | FALSE |
18 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FUT2 | 0.11 | 0.22 | blup | 52 | 0.22 | 6.3e-24 | -5.9 | 6.1 | 1.4e-09 | -0.86 | 0.04 | 0.96 | FALSE |
19 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | FUT2 | 0.10 | 0.01 | blup | 51 | 0.05 | 9.8e-04 | -5.8 | 5.9 | 2.8e-09 | -0.82 | 0.03 | 0.83 | FALSE |
20 | The Cancer Genome Atlas | Brain Lower Grade Glioma | MAMSTR | 0.04 | 0.04 | blup | 47 | 0.06 | 3.9e-07 | 5.3 | -5.7 | 1.1e-08 | 0.83 | 0.15 | 0.84 | FALSE |
21 | The Cancer Genome Atlas | Brain Lower Grade Glioma | NTN5 | 0.05 | 0.04 | lasso | 2 | 0.02 | 6.7e-04 | -5.6 | -5.6 | 2.4e-08 | 0.82 | 0.01 | 0.98 | FALSE |
22 | The Cancer Genome Atlas | Lung Adenocarcinoma | FUT2 | 0.09 | 0.12 | blup | 52 | 0.12 | 4.2e-14 | -5.6 | 5.9 | 2.9e-09 | -0.85 | 0.10 | 0.90 | FALSE |
23 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FUT2 | 0.05 | 0.08 | lasso | 2 | 0.08 | 6.7e-09 | -5.8 | 5.8 | 6.3e-09 | -0.79 | 0.09 | 0.91 | FALSE |
24 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FUT2 | 0.06 | 0.00 | blup | 53 | 0.05 | 3.5e-04 | -6.3 | 5.7 | 1.3e-08 | -0.86 | 0.01 | 0.90 | FALSE |
25 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FUT2 | 0.08 | 0.12 | lasso | 4 | 0.11 | 2.5e-05 | -6.0 | 6.0 | 1.6e-09 | -0.78 | 0.03 | 0.92 | FALSE |
26 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | IZUMO1 | 0.16 | 0.17 | lasso | 7 | 0.15 | 1.4e-06 | 5.8 | -5.8 | 5.2e-09 | 0.86 | 0.12 | 0.86 | FALSE |
27 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FUT2 | 0.05 | 0.06 | blup | 52 | 0.06 | 8.6e-07 | -5.9 | 6.3 | 3.0e-10 | -0.91 | 0.03 | 0.97 | FALSE |
28 | The Cancer Genome Atlas | Rectum Adenocarcinoma | FUT2 | 0.26 | 0.28 | lasso | 10 | 0.22 | 5.2e-06 | -5.6 | 5.9 | 3.7e-09 | -0.86 | 0.06 | 0.90 | FALSE |
29 | The Cancer Genome Atlas | Soft Tissue Sarcoma | RASIP1 | 0.05 | 0.06 | blup | 54 | 0.04 | 1.4e-03 | 5.1 | -5.6 | 2.2e-08 | 0.77 | 0.04 | 0.49 | FALSE |
30 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FUT2 | 0.14 | 0.16 | lasso | 8 | 0.14 | 4.9e-10 | -6.0 | 6.0 | 2.7e-09 | -0.80 | 0.05 | 0.95 | FALSE |
31 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FUT2 | 0.22 | 0.09 | lasso | 8 | 0.13 | 3.0e-05 | 4.0 | 5.8 | 8.5e-09 | -0.71 | 0.05 | 0.92 | FALSE |
32 | The Cancer Genome Atlas | Thyroid Carcinoma | FUT2 | 0.06 | 0.04 | blup | 54 | 0.06 | 1.1e-06 | 5.1 | 6.3 | 2.9e-10 | -0.88 | 0.03 | 0.97 | FALSE |
33 | The Cancer Genome Atlas | Thyroid Carcinoma | NTN5 | 0.11 | 0.07 | blup | 43 | 0.09 | 2.6e-09 | -5.6 | -5.9 | 3.3e-09 | 0.75 | 0.02 | 0.98 | FALSE |